Mount Sinai Health — New York, New York

Mount Sinai Health is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai Health has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Stroke, Acute Ischemic, Mesenchymal Stromal Cells, Remestemcel-L.

Sponsors: Boston Medical Center, Icahn School of Medicine at Mount Sinai, Xenon Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Health?

Mount Sinai Health has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Health conducted?

Mount Sinai Health has 3 clinical trials on record, with 1 currently active. Their work covers Stroke, Acute Ischemic, Mesenchymal Stromal Cells, Remestemcel-L.

Is Mount Sinai Health accredited by Crixeo Health?

Mount Sinai Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.